Event snippet :
top of page
ABR-Biosynth logo.png
Search

Aalto Bio Reagents Launches (VEEV) protein

  • Writer: Rachel O'Reilly
    Rachel O'Reilly
  • Jun 6, 2019
  • 1 min read

Aalto Bio Reagents Launches World's First Commercially Available

Venezuela Equine Encephalitis Virus (VEEV) Protein.

BARCELONA, SPAIN, JUNE 6, 2019 — On the occasion of the 11th International Global Virus Network meeting, Aalto Bio Reagents launches the first commercially available protein for the detection and diagnosis of Venezuela Equine Encephalitis NSP2 TC83.

Click here to read the Press release.


 
 
 

Comments


bottom of page